{
    "Trade/Device Name(s)": [
        "Capillarys Hemoglobin (E)",
        "CAPILLARYS HEMOGLOBIN(E), PN 2007"
    ],
    "Submitter Information": "Sebia, Inc.",
    "510(k) Number": "K052291",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GKA"
    ],
    "Summary Letter Date": "May 15, 2006",
    "Summary Letter Received Date": "May 17, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 864.7515"
    ],
    "Regulation Name(s)": [
        "Abnormal Hemoglobin Assay"
    ],
    "Analyte Class(es)": [
        "hematology"
    ],
    "Analyte(s)": [
        "Hemoglobins",
        "Hemoglobin A",
        "Hemoglobin F",
        "Hemoglobin S",
        "Hemoglobin C",
        "Hemoglobin E",
        "Hemoglobin D"
    ],
    "Specimen Type(s)": [
        "Human blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Sebia CAPILLARYS system"
    ],
    "Method(s)/Technology(ies)": [
        "Capillary electrophoresis",
        "Absorbance detection at 415 nm"
    ],
    "Methodologies": [
        "Electrophoresis",
        "Visual evaluation of electrophoregrams"
    ],
    "Submission Type(s)": [
        "Kit",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for Sebia CAPILLARYS Hemoglobin(E) kit for automated detection and characterization of hemoglobin variants by capillary electrophoresis.",
    "Indications for Use Summary": "Designed for detection and characterization of hemoglobins in human blood with Sebia CAPILLARYS system by capillary electrophoresis for in vitro diagnostic use.",
    "fda_folder": "Hematology"
}